Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor-Reference-Cited by-同舟云学术

Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor

Published:2016-01-21 Issue:5 Volume:57 Page:735-740
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Hyun O Joo,Luber Brandon S.,Leal Jeffrey P.,Wang Hao,Bolejack Vanessa,Schuetze Scott M.,Schwartz Lawrence H.,Helman Lee J.,Reinke Denise,Baker Laurence H.,Wahl Richard L.

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference19 articles.

1. R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study

2. Phase 1 clinical trials for sarcomas: the cutting edge

3. [18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of Tumors

4. Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma

5. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical practice guidelines for the treatment of Ewing sarcoma (Spanish Sarcoma Research Group-GEIS);Clinical and Translational Oncology;2024-08-19

2. Prognostic significance of [18F]FDG PET metabolic parameters in osteosarcoma and Ewing’s sarcoma: a systematic review and network meta-analysis;Clinical and Translational Imaging;2024-05-13

3. Whole-body bioluminescence imaging of T-cell response in PDAC models;Frontiers in Immunology;2023-07-11

4. Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop;The Lancet Oncology;2023-03

5. Utility of Integrated PET/MRI for the Primary Diagnostic Work-Up of Patients with Ewing Sarcoma: Preliminary Results;Diagnostics;2022-09-21